DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: COPAXONE, GLATOPA (glatiramer acetate)
       *****************************************************
       #Post#: 4605--------------------------------------------------
       Teva facing €463M fine over Copaxone misconduct claims
       By: agate Date: October 31, 2024, 8:25 pm
       ---------------------------------------------------------
       Now that there is a plethora of MS drugs available, those who
       enjoy entertaining spectacles can watch while the drug companies
       duke it out for the privilege of getting our insurance company
       dollars (or somebody's dollars/euros)--and often it's a lifetime
       commitment to an MS drug. Here is yet another instance where a
       drug company has gone too far in its attempts at cornering the
       market.
       From FiercePharma (October 31, 2024)--"Teva Slapped with €463M
       Fine over Copaxone Misconduct Claims in EU":
  HTML https://www.fiercepharma.com/pharma/teva-slapped-eu463m-fine-over-accusations-it-stymied-copaxone-competition-europe
       *****************************************************